Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 3
1956 1
1958 2
1959 1
1961 1
1962 4
1963 1
1964 8
1965 4
1966 8
1967 10
1968 7
1969 6
1970 5
1971 7
1972 6
1973 3
1974 2
1975 6
1976 7
1977 2
1978 7
1979 11
1980 8
1981 9
1982 10
1983 20
1984 13
1985 32
1986 39
1987 35
1988 27
1989 33
1990 29
1991 21
1992 34
1993 21
1994 29
1995 23
1996 42
1997 40
1998 37
1999 62
2000 88
2001 70
2002 82
2003 85
2004 82
2005 77
2006 90
2007 86
2008 101
2009 88
2010 119
2011 125
2012 142
2013 170
2014 173
2015 143
2016 153
2017 161
2018 157
2019 160
2020 201
2021 154
Text availability
Article attribute
Article type
Publication date

Search Results

3,084 results
Results by year
Filters applied: . Clear all
Page 1
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.
Shimada K, Yamaguchi M, Atsuta Y, Matsue K, Sato K, Kusumoto S, Nagai H, Takizawa J, Fukuhara N, Nagafuji K, Miyazaki K, Ohtsuka E, Okamoto M, Sugita Y, Uchida T, Kayukawa S, Wake A, Ennishi D, Kondo Y, Izumi T, Kin Y, Tsukasaki K, Hashimoto D, Yuge M, Yanagisawa A, Kuwatsuka Y, Shimada S, Masaki Y, Niitsu N, Kiyoi H, Suzuki R, Tokunaga T, Nakamura S, Kinoshita T. Shimada K, et al. Among authors: suzuki r. Lancet Oncol. 2020 Apr;21(4):593-602. doi: 10.1016/S1470-2045(20)30059-0. Epub 2020 Mar 11. Lancet Oncol. 2020. PMID: 32171071 Clinical Trial.
NK/T Cell Lymphoma: Updates in Therapy.
Suzuki R. Suzuki R. Curr Hematol Malig Rep. 2018 Feb;13(1):7-12. doi: 10.1007/s11899-018-0430-5. Curr Hematol Malig Rep. 2018. PMID: 29368155 Review.
Insulin- and Lipopolysaccharide-Mediated Signaling in Adipose Tissue Macrophages Regulates Postprandial Glycemia through Akt-mTOR Activation.
Toda G, Soeda K, Okazaki Y, Kobayashi N, Masuda Y, Arakawa N, Suwanai H, Masamoto Y, Izumida Y, Kamei N, Sasako T, Suzuki R, Kubota T, Kubota N, Kurokawa M, Tobe K, Noda T, Honda K, Accili D, Yamauchi T, Kadowaki T, Ueki K. Toda G, et al. Among authors: suzuki r. Mol Cell. 2020 Jul 2;79(1):43-53.e4. doi: 10.1016/j.molcel.2020.04.033. Epub 2020 May 27. Mol Cell. 2020. PMID: 32464093
Cell surface flip-flop of phosphatidylserine is critical for PIEZO1-mediated myotube formation.
Tsuchiya M, Hara Y, Okuda M, Itoh K, Nishioka R, Shiomi A, Nagao K, Mori M, Mori Y, Ikenouchi J, Suzuki R, Tanaka M, Ohwada T, Aoki J, Kanagawa M, Toda T, Nagata Y, Matsuda R, Takayama Y, Tominaga M, Umeda M. Tsuchiya M, et al. Among authors: suzuki r. Nat Commun. 2018 May 24;9(1):2049. doi: 10.1038/s41467-018-04436-w. Nat Commun. 2018. PMID: 29799007 Free PMC article.
Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization.
Iwamoto M, Saso W, Sugiyama R, Ishii K, Ohki M, Nagamori S, Suzuki R, Aizaki H, Ryo A, Yun JH, Park SY, Ohtani N, Muramatsu M, Iwami S, Tanaka Y, Sureau C, Wakita T, Watashi K. Iwamoto M, et al. Among authors: suzuki r. Proc Natl Acad Sci U S A. 2019 Apr 23;116(17):8487-8492. doi: 10.1073/pnas.1811064116. Epub 2019 Apr 5. Proc Natl Acad Sci U S A. 2019. PMID: 30952782 Free PMC article.
Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET system.
Kizaki M, Takahashi N, Iriyama N, Okamoto S, Ono T, Usui N, Inokuchi K, Nakaseko C, Kurokawa M, Sumi M, Nakamura F, Kawaguchi T, Suzuki R, Yamamoto K, Ohnishi K, Matsumura I, Naoe T; New TARGET investigators. Kizaki M, et al. Among authors: suzuki r. Int J Hematol. 2019 Apr;109(4):426-439. doi: 10.1007/s12185-019-02613-1. Epub 2019 Feb 14. Int J Hematol. 2019. PMID: 30762219 Clinical Trial.
3,084 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page